Stay updated on Neratinib for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Neratinib for Metastatic Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedA notice was added announcing NIH website transition updates and saying that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.8%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedA new site revision entry v3.7.0 was added. The previous revision v3.6.6 was removed from the record history.SummaryDifference0.1%

- Check63 days agoChange DetectedNew revision entry v3.6.6 is added to the record history, and the previous revision v3.6.5 is removed. This updates the page's release history to reflect the latest version.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry, v3.6.5, was added to the study record history, replacing the previous v3.6.4, indicating a small platform update to the page.SummaryDifference0.1%

Stay in the know with updates to Neratinib for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.